The Diagnosis and Treatment of Systemic Lupus Erythematosus.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Deutsches Ärzteblatt International

• Publication date

  2015-06-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.3238/arztebl.2015.0423PMID 26179016PMCID PMC4558874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A prospective analysis of the effects of enteric-coated mycophenolate sodium and mycophenolate mofetil co-medicated with a proton pump inhibitor in kidney transplant recipients at a single institute in China.

  2014cited by this paper
• Systemic lupus erythematosus

  2014cited by this paper
• Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects

  2014cited by this paper
• A surge in anti-dsDNA titer predicts a severe lupus flare within six months

  2014cited by this paper
• Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: systematic review and meta-analysis.

  2014cited by this paper
• Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy

  2014cited by this paper
• Age-specific prevalence of diagnosed systemic lupus erythematosus in Germany 2002 and projection to 2030

  2014cited by this paper
• Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database

  2014cited by this paper
• [Statement on the use of mycophenolate mofetil for systemic lupus erythematosus].

  2013cited by this paper
• Stellungnahme zum Einsatz von Mycophenolat-Mofetil beim systemischen Lupus erythematodes

  2013cited by this paper
• [Recommendation for use of belimumab for systemic lupus erythematosus].

  2013cited by this paper
• Empfehlungen zum Einsatz von Belimumab beim systemischen Lupus erythematodes

  2013cited by this paper
• Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies

  2013cited by this paper
• An update on childhood-onset systemic lupus erythematosus

  2013cited by this paper
• Früher Lupus erythematosus

  2013cited by this paper
• Rheumatische Erkrankungen in der Schwangerschaft

  2012cited by this paper
• Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

  2012cited by this paper
• Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

  2012cited by this paper
• Treatment for lupus nephritis.

  2012cited by this paper
• Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

  2012cited by this paper
• Entwicklung von Mortalität und Morbidität beim systemischen Lupus erythematodes

  2011cited by this paper
• Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus

  2011cited by this paper
• [Skin manifestations in lupus erythematosus: clinical aspects and therapy].

  2011cited by this paper
• Cutaneous lupus erythematosus: update of therapeutic options part I.

  2011cited by this paper
• Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial.

  2011cited by this paper
• Use of antimalarials in dermatology

  2010cited by this paper
• Lupus Erythematosus Tumidus: Response to Antimalarial Treatment in 36 Patients With Emphasis on Smoking

  2010cited by this paper
• Drug-induced lupus: an update.

  2010cited by this paper
• Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.

  2010cited by this paper
• EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

  2010cited by this paper
• EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

  2010cited by this paper
• Histopathologic manifestations of systemic diseases: the example of cutaneous lupus erythematosus

  2010cited by this paper
• Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus

  2010cited by this paper
• Update on systemic lupus erythematosus pregnancy.

  2010cited by this paper
• Einsatz von Antimalariamitteln in der Dermatologie

  2010cited by this paper
• European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

  2009cited by this paper
• EULAR-Empfehlungen zur Behandlung des systemischen Lupus erythematodes

  2009cited by this paper
• The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine

  2009cited by this paper
• Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.

  2009cited by this paper
• Antimalariamittel: Therapieoption für jeden Lupus-Patienten?!

  2009cited by this paper
• Antimalariamittel

  2009cited by this paper
• Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.

  2009cited by this paper
• Hydroxychloroquine: the cornerstone of lupus therapy

  2008cited by this paper
• Previous antimalarial therapy in patients diagnosed with lupus nephritis: Influence on outcomes and survival

  2008cited by this paper
• Topical calcineurin inhibitors in cutaneous lupus erythematosus

  2008cited by this paper
• The relation between sun protection factor and amount of sunscreen applied in vivo

  2008cited by this paper
• EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

  2007cited by this paper
• The relation between sun protection factor and amount of suncreen applied in vivo

  2007cited by this paper
• Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis

  2006cited by this paper
• [Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses].

  2006cited by this paper
• Antimalarial agents: closing the gate on Toll-like receptors?

  2006cited by this paper
• Hydroxychloroquine in lupus pregnancy.

  2006cited by this paper
• Systemischer Lupus erythematodes

  2006cited by this paper
• Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis

  2006cited by this paper
• The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus.

  2005cited by this paper
• Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual.

  2005cited by this paper
• [Systemic lupus erythematosus].

  2005cited by this paper
• Classification of Cutaneous Lupus Erythematosus

  2005cited by this paper
• Prognostic factors in systemic lupus erythematosus

  2004cited by this paper
• The classification of glomerulonephritis in systemic lupus erythematosus revisited.

  2004cited by this paper
• The classification of glomerulonephritis in systemic lupus erythematosus revisited.

  2004cited by this paper
• Systemischer Lupus erythematodes

  2003cited by this paper
• Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients

  2003cited by this paper
• Can morbidity and mortality of SLE be improved?

  2002cited by this paper
• Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.

  2002cited by this paper
• Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.

  2002cited by this paper
• Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.

  2000cited by this paper
• Morbidity and mortality in systemic lupus erythematosus during a 5-year period - A multicenter prospective study of 1,000 patients

  1999cited by this paper
• Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus.

  1999cited by this paper
• Evolving spectrum of mortality and morbidity in SLE

  1999cited by this paper
• Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

  1997cited by this paper
• Retinal toxicity in long term hydroxychloroquine treatment.

  1996cited by this paper
• The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

  1996cited by this paper
• Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

  1993cited by this paper
• Systemic Lupus Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of 1,000 Patients

  1993cited by this paper
• Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

  1990cited by this paper
• The treatment of lupus nephritis

  1989cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• Distinctive cutaneous subsets in the spectrum of lupus erythematosus.

  1981cited by this paper

• Association of systemic lupus erythematosus with clinical and psychosocial outcomes, health care resource utilization and expenditures: A nationally representative US-based analysis.

  2026cites this paper
• Efficacy of Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in the Treatment of Patients with Systemic Lupus Erythematosus—Randomized Crossover Clinical Study

  2025cites this paper
• Beyond the Autoimmune Spectrum, Evaluating Ovarian Health in Systemic Lupus Erythematosus Patients: A Case‐Control Study

  2025cites this paper
• Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

  2025cites this paper
• Antiphospholipid Syndrome Coexisting With Evans Syndrome and SCL‐70 Antibody Positivity: A Case Report

  2025cites this paper
• Effects of glucocorticoid withdrawal on relapse risk in systemic lupus erythematosus: A systematic review and meta-analysis

  2025cites this paper
• Severe Warm Autoimmune Hemolytic Anemia With Anti-PO Antibody Positivity: A Diagnostic Dilemma in a Resource-Limited Setting

  2025cites this paper
• Beyond conventional treatment: Novel cell therapies for systemic lupus erythematosus

  2025cites this paper
• Astragalus-containing Chinese herbal medicine used with Western medicine for lupus nephritis: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Recurrent pregnancy loss and fetal complete heart block as the initial manifestations of maternal systemic lupus erythematosus: a case report on the diagnostic and preventive role of anti-SSA (Ro) antibodies

  2025cites this paper
• ActiLup: is it feasible? High-intensity interval training in systemic lupus erythematosus patients with fatigue: protocol for a prospective, monocentric proof-of-concept study

  2025cites this paper
• Mesothelin in pancreatic cancer: clinical applications and analytical considerations.

  2025cites this paper
• Epigenetic modifier m⁶A methylation: insights into the pathogenesis and therapeutic potential of autoimmune diseases

  2025cites this paper
• A case report and literature review on new-onset systemic lupus erythematosus leading to thrombocytopenia in a hemodialysis patient

  2025cites this paper
• Exploring the correlation between UVB sensitivity and SLE activity: Insights into UVB-driven pathogenesis in lupus erythematosus.

  2025cites this paper
• Phytochemicals As Nutraceuticals: A Review

  2025cites this paper
• Identification of Key Biomarkers for Systemic Lupus Erythematosus Progression and Therapy Response: A Bulk RNA‐Sequencing‐Based Bioinformatics Study

  2025cites this paper
• How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus

  2025cites this paper
• Outcomes following total shoulder arthroplasty in patients with systemic lupus erythematosus.

  2024cites this paper
• A leakage-resistant catalytic hairpin assembly for ultrasensitive detection of miRNA-146a in systemic lupus erythematosus

  2024cites this paper
• Current Pathogenesis and Treatment of Autoimmune Diseases

  2024influential citation
• Generalized discoid lupus erythematosus preceding systemic lupus erythematosus

  2024cites this paper
• Evaluating treatment effect on interferon-alpha in female patients with systemic lupus erythematosus: a case-control study.

  2024cites this paper
• Clinical and Hematological Manifestations of Systemic Lupus Erythematosus at Initial Presentation in a Tertiary Healthcare Center

  2024cites this paper
• Malignancy in systemic lupus erythematosus: relation to disease characteristics in 92 patients – a single center retrospective study

  2024cites this paper
• Associations Between Serum Autoantibodies, Cytokines, Complements, and Clinical Manifestations in SLE Patients

  2024cites this paper
• Interplay between the Chaperone System and Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus Pathogenesis: Is Molecular Mimicry the Missing Link between Those Two Factors?

  2024cites this paper
• Increased serum human epididymis protein 4 is associated with disease activity and systemic involvement in pediatric-onset systemic lupus erythematosus

  2024cites this paper
• Animal models of studying the pathogenesis of multi-organ tissue damage in lupus.

  2024cites this paper
• Oral Lesion Management in Juvenile SLE with Hepatosplenomegaly

  2024cites this paper
• TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus

  2024cites this paper
• The economic burden of systemic lupus erythematosus in Taiwan

  2024cites this paper
• Economic burden of systemic lupus erythematosus in Malaysia

  2024cites this paper
• Health-Related Quality of Life in Systemic Lupus Erythematosus and Its Relationship With Disease Activity: A Single-Center Cross-Sectional Study From Pakistan

  2024cites this paper
• Recent Advances in Biosensors for Diagnosis of Autoimmune Diseases

  2024cites this paper
• Regional variations in serum IL-35 levels and association with systemic lupus erythematosus: a systematic review and meta-analysis

  2024cites this paper
• The Dynamic Role of PD-1, Vitamin D, RANKL, and Sclerostin in Iraqi Patients with Systemic Lupus Erythematosus

  2024cites this paper
• Microsimulation model of the cost-effectiveness of anifrolumab compared to belimumab in the United Arab Emirates

  2024cites this paper
• The Effectiveness of Rituximab in the Treatment of Refractory Manifestations of Patients with Systematic Lupus Erythematous: A Retrospective Study

  2024cites this paper
• Evaluate Interleukin-15 in SLE patients and its association with hemolytic anemia

  2024cites this paper
• Potential Therapeutic Application and Mechanism of Action of Stem Cell-Derived Extracellular Vesicles (EVs) in Systemic Lupus Erythematosus (SLE)

  2024cites this paper
• Proxy-reported health-related quality of life of children with systemic lupus erythematosus and well-being of caregivers: a cross-sectional survey among caregivers in China

  2024cites this paper
• A comparison of VCAM-1 and ICAM-1 as atherosclerosis risk factors in patients with systemic lupus erythematosus from Iraq

  2023cites this paper
• Lupus eritematoso sistémico en pediatría. Reporte de caso y revisión de la literatura

  2023cites this paper
• Elevated Serum Levels of Soluble Transferrin Receptor Are Associated with an Increased Risk of Cardiovascular, Pulmonary, and Hematological Manifestations and a Decreased Risk of Neuropsychiatric Manifestations in Systemic Lupus Erythematosus Patients

  2023cites this paper
• Acute pancreatitis secondary to acute undiagnosed lupus: A case report

  2023cites this paper
• Identi�cation of Predicting Diagnostic Gene Biomarkers through Machine Learning combined with Pan-cancer in Patients with Systemic Lupus Erythematosus

  2023cites this paper
• Fever and rash as initial signs of systemic autoimmune disease. Case Report.

  2023cites this paper
• Comparison between oral Mycophenolate Mofetil and intravenous Cyclophosphamide for the treatment of the lupus nephritis patients

  2023cites this paper
• A Case of Fibrinous Pericardial Effusion: Masquerading Presentation of Systemic Lupus Erythematosus

  2023cites this paper
• Serological and clinical associations of autoantibodies in Chinese patients with new-onset systemic lupus erythematosus

  2023cites this paper
• Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study.

  2023cites this paper
• Mycophenolic acid directly protects podocytes by preserving the actin cytoskeleton and increasing cell survival

  2023cites this paper
• A Review of the Potential Benefits of Herbal Medicines, Small Molecules of Natural Sources, and Supplements for Health Promotion in Lupus Conditions

  2023cites this paper
• Hospitalization and outcome of systemic lupus erythematosus patients admitted to the Rheumatology ward of Kasr Al-Ainy University Hospital

  2023cites this paper
• Evaluation of Anti-Nuclear Antibodies and Anti-dsDNA Serum Levels in Patients with Suspected Systemic Lupus Erythematosus

  2023cites this paper
• Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives

  2023cites this paper
• Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects

  2023cites this paper
• Prevalence of oral mucosal lesions in patients with systemic Lupus Erythematosus: a systematic review and meta-analysis

  2023cites this paper
• Uncertainty and its related coping strategies in systemic lupus erythematosus. Life in the fog

  2023cites this paper
• Clinical Assessment of Cytokine Profiles and Haematological Parameters in Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study from Saudi Arabia.

  2023cites this paper
• Serum Vitamin D3 and Osteocalcin Levels in Iraqi Females with Lupus Erythematosus and their Relationship to Disease Severity

  2023cites this paper
• Screening Biomarkers for Systemic Lupus Erythematosus Based on Machine Learning and Exploring Their Expression Correlations With the Ratios of Various Immune Cells

  2022cites this paper
• Association between IL-35 Gene Single Nucleotide Polymorphisms and Systemic Lupus Erythematosus in Egypt

  2022cites this paper
• Serum alpha-1-antitrypsin level in the severity prognosis of systemic lupus erythematosus patients: Systematic exploration of novel biomarker

  2022cites this paper
• Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review

  2022cites this paper
• Evaluation of subclinical retinal microvascular changes in systemic lupus erythematosus patients using optical coherence tomography angiography and its relationship with disease activity

  2022cites this paper
• Single-cell analysis of skin immune cells reveals an Angptl4-ifi20b axis that regulates monocyte differentiation during wound healing

  2022cites this paper
• Immunomodulatory effects of curcumin in systemic autoimmune diseases

  2022cites this paper
• An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States

  2022cites this paper
• Butterfly Rash

  2022cites this paper
• Down-regulated ALKBH5 Expression Could Affect the Function of T Cells in Systemic Lupus Erythematosus Patients.

  2022cites this paper
• Autoimmune diseases and the role of Toll-like receptor-7 and -9 signaling cascades

  2022cites this paper
• Establishment and analysis of a disease risk prediction model for the systemic lupus erythematosus with random forest

  2022cites this paper
• Prevalence and Patterns of Renal Involvement Among Patients With Systemic Lupus Erythematous at a Tertiary Center

  2022cites this paper
• Comparison of Maternal and Perinatal Outcomes of Pregnancy with Systemic Lupus Erythematosus in Planned Referrals Compared to Emergency Referrals Based on the Maternal Fetal Triage Index at Dr. Kariadi General Hospital, Semarang, Indonesia

  2022cites this paper
• Experimental Spectroscopy, Eco-friendly solvents effect on transitions, Reactive sites and Biological research on Methyl Gallate - MTT assay (cytotoxicity)

  2022cites this paper
• Early onset of immune-mediated diseases in minority ethnic groups in the UK

  2022cites this paper
• Bilateral Lupus Chorioretinopathy in a Patient With Active Systemic Lupus Erythematosus

  2022cites this paper
• Implicações materno-fetais e neonatais do lúpus eritematoso sistêmico durante a gravidez: uma revisão integrativa

  2022cites this paper
• Cross Talk between Mesenchymal Stem/Stromal Cells and Innate Immunocytes Concerning Lupus Disease

  2022cites this paper
• Endometriosis and Systemic Lupus Erythematosus: Systematic Review and Meta-analysis

  2022cites this paper
• Dysregulation of immunity in COVID-19 and SLE

  2022cites this paper
• Cardiovascular Complications in Systemic Lupus Erythematosus

  2022cites this paper
• Gambaran profil systemic lupus erythematosus (SLE) dan lupus nefritis di Rumah Sakit Umum Pusat Sanglah

  2022cites this paper
• Don’t Miss Lupus

  2021cites this paper
• Guillain - Barre syndrome as the first presentation in a patient with systemic lupus erythromatous; case report

  2021cites this paper
• Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life

  2021cites this paper
• A Review of the Efficacy of Influenza Vaccination in Autoimmune Disease Patients

  2021cites this paper
• Lupus eritematoso sistémico

  2021cites this paper
• Miejsce hydroksychlorochiny we współczesnej dermatologii

  2021cites this paper
• A Case of New-Onset Systemic Lupus Erythematosus With Serositis in a Maintenance Hemodialysis Patient

  2021cites this paper
• A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Faslpr mice with proliferative lupus nephritis predicts low effect size.

  2021cites this paper
• Systemic Lupus Erythematosus (SLE)

  2021cites this paper
• RNA Methylation in Systemic Lupus Erythematosus

  2021cites this paper
• Exploring intentional medication non-adherence in patients with systemic lupus erythematosus: the role of physician–patient interactions

  2021cites this paper
• The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021.

  2021cites this paper
• Studi Retrospektif Penggunaan Obat dan Potensi Interaksi Obat Pasien Systemic Lupus Erythematosus

  2021cites this paper
• Development of a digital toolkit to improve quality of life of patients with systemic lupus erythematosus

  2021cites this paper
• Immune-Mediated Hematological Disorders as Uncommon Presentation Forms of Systemic Lupus Erythematosus

  2021cites this paper